The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Kane Biotech Inc closed at $0.05.

This security is unchanged over the last five days and the last 52 weeks. This security has outperformed the S&P TSX by 26.72% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.02
Updated at previous session's close. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1,606.67%

Although this company's net profit margin is negative, it is above the industry average and implies that Kane Biotech Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Biotechnology

Latest Company News

    No News Results.

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit0000
Total cost of revenue0000
Total operating expense0000
Selling / general / administrative0000
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total00----
Operating income0000
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets00--0
Other--------
Income before tax0000
Income after tax0000
Income tax, total------0
Net income0000
Total adjustments to net income--------
Net income before extra. items0000
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items0000
Inc. avail. to common incl. extra. items0000
Diluted net income0000
Dilution adjustment----0--
Diluted weighted average shares10810710783
Diluted EPS excluding extraordinary itemsvalue per share0.000.000.00-0.01
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.000.000.00-0.01